RNAi Archives -

Novo Nordisk’s gene silencing alliance with Dicerna bears first fruit

https://pharmaphorum.com/news/novo-nordisks-gene-silencing-alliance-with-dicerna-bears-first-fruit/

Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast

https://pharmaphorum.com/podcast/alnylam-gene-silencing-biotech-2020/

Sanofi and Alnylam conclude research phase of RNAi alliance

https://pharmaphorum.com/news/sanofi-and-alnylam-conclude-research-phase-of-rnai-alliance/

Alnylam hopes for 2018 filing for RNAi liver disease drug

https://pharmaphorum.com/news/alnylam-hopes-2018-filing-rnai-liver-disease-drug/

Sanofi passes on Alnylam’s breakthrough therapy

https://pharmaphorum.com/news/sanofi-passes-alnylams-breakthrough-therapy/

Topics Presented this February 2018 at RNA Therapeutics

https://pharmaphorum.com/partner-content-oncology/topics-presented-this-february-2018-at-rna-therapeutics/

Alnylam beats Ionis in RNA drug battle

https://pharmaphorum.com/news/sanofialnylam-improve/

Alnylam soars after drug success, paving way for RNAi era

https://pharmaphorum.com/news/alnylam-shares-jump-rnai-drug-succeeds-rare-disease-trial/

Alnylam a ‘premier league’ addition to UK biotech

https://pharmaphorum.com/news/alnylam-premier-league-addition-uk-biotech/

Search